Increased risk of central serous chorioretinopathy following end-stage renal disease: A nationwide population-based study

Medicine (Baltimore). 2019 Mar;98(11):e14859. doi: 10.1097/MD.0000000000014859.

Abstract

This retrospective, nationwide, matched cohort study investigated the risk of central serous chorioretinopathy (CSCR) following end-stage renal disease (ESRD). The study cohort included 84722 ESRD patients who were registered between January 2000 and December 2009 at the Taiwan National Health Insurance Research Database. An age- and sex-matched control group comprised 84722 patients selected from the Taiwan Longitudinal Health Insurance Database 2000. We collected information for each patient from the index date until December 2011. During the follow-up period, we found a significantly elevated risk of CSCR in the ESRD patients compared with controls (incidence rate ratio = 1.51, 95% confidence interval = 1.24-1.84). After adjustment for potential confounders, including age, sex, coronary artery disease, peptic ulcer, and obstructive sleep apnea, ESRD patients were 1.41 times more likely to develop CSCR (adjusted hazard ratio = 1.41, 95% confidence interval = 1.14-1.73). In conclusion, we found that ESRD patients showed a significantly higher risk of developing CSCR and recommend regular retina examinations and education regarding CSCR for patients with ESRD.

MeSH terms

  • Aged
  • Central Serous Chorioretinopathy / epidemiology
  • Central Serous Chorioretinopathy / etiology*
  • Cohort Studies
  • Complement Factor H / analysis
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / epidemiology
  • Male
  • Middle Aged
  • National Health Programs / organization & administration
  • National Health Programs / statistics & numerical data
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Taiwan / epidemiology

Substances

  • Complement Factor H